Although immune checkpoint inhibitors (ICIs) have improved outcomes in certain patients with cancer, they can also cause life-threatening immunotoxicities. Predicting immunotoxicity risks alongside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback